Medicine
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||
Spotlight
-
Life extension sought for UK's oldest nuclear plant
The UK Nuclear Decommissioning Authority (NDA) has appealed to the Nuclear Insta...
-
Indo-US Nuclear Deal Off to a Flying Start
The Indo-US civilian nuclear energy deal has got off to a flying start. This w...
-
Slovakia launches work on two N-energy reactors with $3.6 bn investment
Slovakia is building two nuclear reactors that will cover 22 percent of the coun...
-
Australia’s Energy & Minerals to Raise Funds for Uranium Project
Energy & Minerals Australia Ltd. plans to raise money within the next three ...

- India Plans Exports of AHW Reactors Fuelled by LEU
- India’s Three-Phased N-Power Programme
- Asia Remains Focus of N-Energy Growth
- The Dilemma of Aging Nuclear Plants
- SCHOTT’s ‘Fit & Forget’ EPAs Offer Best Bet for N-Reactors
- IOCL Poised to Play Big Role in India’s N-Power Development
- NPCIL Assessing Orissa State’s Potential for N-Power Complex





A 52-year-old Canadian nuclear facility, producer of medical isotopes leaked radioactive water during a power outage, federal regulators said.
Belgium's nuclear regulator has given the go-ahead for the production of medical isotopes at the Institute of Radioelements (IRE) at Fleurus. The facility, which manufactures a range of isotopes by processing 'targets' exposed to radiation in research reactors, had been out of action since an unexpected release of iodine-131 in August. This extended outage had added to other problems to result in a global shortage of materials for nuclear medicine.







